Skip to main content
Equibles
EIKN logo

EIKN · Eikon Therapeutics, Inc. · Executive Compensation

Track EIKN — free

Use EIKN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research EIKN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$7.54 +0.21 (+2.86%) At close · Oct 5
Russell 2000 member Rebalance outlook locked
Market Cap
$408.40M
Shares
54.17M
Volume · Oct 5 485.36K Avg daily vol (3M) 484.72K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

No Compensation Data

No Summary Compensation Table has been imported from this company's proxy statements yet.

Executive changes

Person Change Filed
Joshua Wolfe Resigned 2026-08-03
Leon Chen, Ph.D. Resigned 2026-08-03
Ma. Fatima D. Francisco Appointed 2026-06-10
Key facts CIK 1861123 CUSIP 282564103 13F (30d) 3 filings 3 filers Visit website Investor relations